Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Neoplasms by Histologic Type × Taxes × 90 days × Clear all

Sponsor

Conditions

Pancreatic Neoplasms 14 Ovarian Neoplasms 11 Carcinoma, Non-Small-Cell Lung 11 Fallopian Tube Neoplasms 10 Neoplasm Metastasis 9 Lung Neoplasms 7 Endometrial Neoplasms 7 Breast Neoplasms 6 Triple Negative Breast Neoplasms 5 Squamous Cell Carcinoma of Head and Neck 4 Oropharyngeal Neoplasms 3 Mouth Neoplasms 3 Laryngeal Neoplasms 3 Hypopharyngeal Neoplasms 3 Carcinoma 3 Neoplasms 2 Esophageal Neoplasms 2 Colorectal Neoplasms 2 Cholangiocarcinoma 2 Carcinoma, Transitional Cell 2 Carcinoma, Squamous Cell 2 Brenner Tumor 2 Anatomic Stage II Breast Cancer AJCC v8 2 Adenocarcinoma of Lung 2 Adenocarcinoma Of Esophagus 2 Urinary Bladder Neoplasms 1 Thyroid Neoplasms 1 Thyroid Carcinoma, Anaplastic 1 Stomach Neoplasms 1 Sinonasal Squamous Cell Carcinoma 1

Interventions

fludarabine phosphate 2 fludarabine 2 Whole-Body Irradiation 2 Tacrolimus 2 Peripheral Blood Stem Cell Transplantation 2 Patient Reported Outcome Measures 2 Mycophenolic Acid 2 Mesna 2 Melphalan 2 Cyclophosphamide 2 Cisplatin 2 Busulfan 2 trametinib 1 pralsetinib 1 ponatinib 1 pembrolizumab 1 durvalumab 1 dabrafenib 1 Radiotherapy, Intensity-Modulated 1 Pemetrexed 1 Paclitaxel 1 Nimorazole 1 Immunotherapy 1 Gemcitabine 1 Carboplatin 1 Bone Marrow Transplantation 1 Biopsy 1 Bevacizumab 1 130-nm albumin-bound paclitaxel 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡